Back
Allstate Corporation (The) (ALL)
InsuranceALL · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$251.55
+1.15%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$38.49
ROE
45.2%
Gross margin
34.4%
Debt/Equity
0.24x
Revenue growth
3.0%
Allstate Corporation (The) — company intelligence
Earnings surprises
Q1 2026$10.65 vs $7.36 est+44.7%
Q4 2025$14.31 vs $9.96 est+43.7%
Q3 2025$11.17 vs $7.62 est+46.6%
Q2 2025$5.94 vs $3.32 est+78.9%
Insider activity · 90 days
13 buys2 sellsnet +7,925 shares
KEANE MARGARET MBuy 138 · Jul 1, 2026
Perold Jacques PBuy 174 · Jul 1, 2026
TRAQUINA PERRY MBuy 169 · Jul 1, 2026
Recent SEC filings
4 — Insider transaction reportJul 7, 2026
4 — Insider transaction reportJul 6, 2026
4 — Insider transaction reportJul 6, 2026
Latest news
HSBC Downgrades Allstate (ALL) — Fintel · 4d ago
Allstate to hold Q2 2026 earnings call Aug. 6, 2026 — Yahoo · 4d ago
Raymond James Maintains Strong Buy on Allstate, Raises Price Target to $300 — Benzinga · 4d ago
Morgan Stanley Maintains Equal-Weight on Allstate, Raises Price Target to $240 — Benzinga · 5d ago
HSBC Downgrades Allstate to Hold, Raises Price Target to $264 — Benzinga · 5d ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Allstate Corporation (The)
Weekly undervalued picks (like ALL)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.